October 22, 2019 - Paul-Ehrlich-Institut, Langen, Germany

Quality Requirements for Challenge Agents
An IABS-EU Meeting

 

  Information about the meeting here

 

Meeting Objectives
One of the proposed tools for faster development of new vaccines is CHIM: Controlled Human Infectious Models. These models can be used for early PoC (Proof of Concept) and as a basis for clinical  “Go/No Go” decisions, in particular if sporadic epidemiology impedes clinical development.
In these models researchers will use a challenge agent: a virus, bacterium or parasite. Frequently questions are raised on the quality of the agent. Should this agent be produced following GMP? What strain-related information is relevant?  Should it be attentuated or resemble the wild type?

These questions will be discussed during this symposium, more information will follow soon

View the Agenda

 

International Alliance for Biological Standardization


Twitter Feed

Examples of networks to address transdisciplinary issues related to infectious disease prevention and vaccine devel… https://t.co/HmhZmZFHn9
#IABS 65 conference on Infectious diseases, LYON. John Edmunds (London School of Tropical Hygiene & Medicine): Real… https://t.co/TYd0mOS3zC
Follow IABS_global on Twitter

Contact Info

IABS, Rue de la Vallée, 3
CH-1204 Geneva

Switzerland
+ 41 22 301 10 36
+ 41 22 301 10 37
This email address is being protected from spambots. You need JavaScript enabled to view it.